Stock Price

Discussion in 'Pfizer' started by anonymous, Aug 4, 2016 at 10:28 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Isn't one of the jobs of a CEO and his cronies to get the price of the stock to go up rather than down. Just when Wall Street started to believe in the growth story of Pfizer, our illustrious CEO who believes he is the smartest man in the world makes some comments about why it is negative to split the company up, and the stock craters 5% in two days, really. It's like the Barron's article said, Really, "We have been waiting for this for five years". What has really changed? Sell the generic business (low or no growth), get smaller, buy smaller companies with potentially good patented growth products, and grow allowing the stock price to go up.
     

  2. anonymous

    anonymous Guest

    Leadership at this company has been nothing short of immensely stupid the past 20 years. All yes men and cronies surrounding a dumb as shit CEO. No wonder we all have worthless stock options dating back to the early 2000's.
     
  3. anonymous

    anonymous Guest

    Optionality is dead. I guess are illustrious CEO wants to continue to drive the price of our stock down. Whatever happened to creating share holder value. He is playing with Wall Street. They don't like that. Pfizer is dead man walking as far as Wall Street is concerned.
     
  4. anonymous

    anonymous Guest

    PFE Owns the Street. Where'd you get your info, from a Cracker Jack box ? Read isn't splitting core now.
     
  5. anonymous

    anonymous Guest

    Stock price high before decision $37.39. Stock price today $32.27. Wall Street clearly punishing Ian Read for playing games with them over the last 3 or 4 years. Ian always says shareholders are important, well his decision has screwed them. Wouldn't be surprised if Wall Street punished the stock down to the high 20's.
     
  6. anonymous

    anonymous Guest

    How much further will the stock price drop due to our inept CEO. First Astra Zeneca, then Allerghan, and now the stock price is down to $29.87, roughly a 20% drop from is's high. So much for creating shareholder value. Will Ian Read take responsibility for his decisions. If he
    doesn't will the BOD do the right thing.